Home / Tiagabine / United States
US ATC N03AG06 · updated 2 Nov 2026
Tiagabine shortage in United States
Is there a Tiagabine shortage in United States?
Yes. As of 2 Nov 2026, 4 Tiagabine products are reported short in United States, the first since 15 Apr 2026. No return date has been given. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Tiagabine Hydrochloride, Tablet, 12mg 30 count (NDC 0093-8072-56) discontinuation | Teva Pharmaceuticals USA, Inc. | 15 Apr 2026 | not given | Not stated |
| US | Tiagabine Hydrochloride, Tablet, 16mg 30 count (NDC 0093-8076-56) discontinuation | Teva Pharmaceuticals USA, Inc. | 15 Apr 2026 | not given | Not stated |
| US | Tiagabine Hydrochloride, Tablet, 2mg 30 count (NDC 0093-5030-56) discontinuation | Teva Pharmaceuticals USA, Inc. | 15 Apr 2026 | not given | Not stated |
| US | Tiagabine Hydrochloride, Tablet, 4mg 30 count (NDC 0093-5031-56) discontinuation | Teva Pharmaceuticals USA, Inc. | 15 Apr 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).